GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general med...
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
- Conditions
- First Posted Date
- 2002-09-30
- Last Posted Date
- 2013-02-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 100
- Registration Number
- NCT00046332
- Locations
- πΊπΈ
GSK Clinical Trials Call Center, Houston, Texas, United States
Prevention of Seasonal Affective Disorder
- Conditions
- First Posted Date
- 2002-09-25
- Last Posted Date
- 2017-01-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 300
- Registration Number
- NCT00046241
- Locations
- π¨π¦
GSK Clinical Trials Call Center, Sherbrooke, Quebec, Canada
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
- First Posted Date
- 2002-09-23
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT00046111
- Locations
- π¨π¦
GSK Investigational Site, Ottawa, Ontario, Canada
Efficacy and Safety In Poorly Controlled Type 2 Diabetics
- Conditions
- First Posted Date
- 2002-08-30
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 142
- Registration Number
- NCT00044460
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
- Conditions
- First Posted Date
- 2002-08-28
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 80
- Registration Number
- NCT00044343
- Locations
- π¨π¦
GSK Clinical Trials Call Center, Sainte-Foy, Quebec, Canada
Pediatric Epilepsy Study in Subjects 1-24 Months
- Conditions
- First Posted Date
- 2002-08-26
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 197
- Registration Number
- NCT00044278
- Locations
- πΉπ·
GSK Investigational Site, Ankara, Turkey
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
- Conditions
- First Posted Date
- 2002-08-19
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 60
- Registration Number
- NCT00043888
- Locations
- π¬π§
GSK Clinical Trials Call Center, Manchester, United Kingdom
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
- Conditions
- First Posted Date
- 2002-08-16
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 760
- Registration Number
- NCT00043927
- Locations
- π¬π§
GSK Clinical Trials Call Center, Poole, United Kingdom
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
- Conditions
- First Posted Date
- 2002-08-16
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 72
- Registration Number
- NCT00043914
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
- Conditions
- First Posted Date
- 2002-08-16
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 141
- Registration Number
- NCT00043901
- Locations
- π΅πͺ
GSK Investigational Site, San Isidro, Lima, Peru